Screener
BMED vs TMED
iShares Health Innovation Active ETF vs T. Rowe Price Health Care ETF
Key differences
- TMED costs 0.11% less per year.
- BMED covers north america markets; TMED covers global.
- BMED has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| BMED | TMED | |
|---|---|---|
| Annual cost (TER) | 0.55% | 0.44% |
| Fund size (AUM) | $10M | $19M |
| Since | 2020 | 2025 |
| Dividend yield | 0.00% | — |
| Asset class | equity | equity |
| Region | north america | global |
| Strategy | active selection | active selection |
| CAGR 1Y | +18.7% | N/A |
| CAGR 3Y | +4.8% | N/A |
| CAGR 5Y | +0.1% | N/A |
| Sharpe 3Y | 0.16 | N/A |
| Volatility 1Y | 14.93% | — |
| Max drawdown | -36.44% | -11.11% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to BMED and TMED
Explore further